Related references
Note: Only part of the references are listed.Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection
Kazuaki Negishi et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy Follow-Up Study of Heart Failure
Sinziana Seicean et al.
CIRCULATION-HEART FAILURE (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Cardioncology: State of the heart
Maria Chiara Todaro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
Xavier Bosch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Independent and Incremental Value of Deformation Indices for Prediction of Trastuzumab-Induced Cardiotoxicity
Kazuaki Negishi et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2013)
Cardiotoxicity Debated for Anthracyclines and Trastuzumab in Breast Cancer
Vicki Brower
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice
M. Khair ElZarrad et al.
PLOS ONE (2013)
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2013)
Using cardiac biomarkers and treating cardiotoxicity in cancer
Alessandro Colombo et al.
FUTURE CARDIOLOGY (2013)
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Edward H. Romond et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy An Observational Clinical Cohort Study
Sinziana Seicean et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
Erin J. Aiello Bowles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Administration of Angiotensin-Converting Enzyme Inhibitors and β-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?
Stefano Oliva et al.
ONCOLOGIST (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
M. Aapro et al.
ANNALS OF ONCOLOGY (2011)
Lack of Uniformity in Cardiac Assessment during Trastuzumab Therapy
Milayna Subar et al.
BREAST JOURNAL (2011)
The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II-Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy
Nazanin Fallah-Rad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Daniela Cardinale et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies Are Clinicians Responding Optimally?
Geoffrey J. Yoon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
Douglas B. Sawyer et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma
Emer O. Hanrahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Early breast cancer therapy and cardiovascular injury
Lee W. Jones et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
Arduino Verdecchia et al.
LANCET ONCOLOGY (2007)
Trastuzumab-related cardiotoxicity: Calling into question the concept of reversibility
Melinda L. Telli et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Correlative analyses of plasma cytokine/angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of first-line vandetanib (VAN) and/or carboplatin plus paclitaxel (CP) for advanced non-small cell lung cancer (NSCLC)
E. O. Hanrahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith et al.
LANCET (2007)
Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity
Maurizio Civelli et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
